chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Disorientation, Dizziness, Fatigue, Feeling abnormal
Clinical narrative: decreased appetite; dizziness; disorientation; felt out of it; nausea; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (decreased appetite), DIZZINESS (dizziness), DISORIENTATION (disorientation), FEELING ABNORMAL (felt out of it) and NAUSEA (nausea) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030120A and 013A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DECREASED APPETITE (decreased appetite), DIZZINESS (dizziness), DISORIENTATION (disorientation), FEELING ABNORMAL (felt out of it), NAUSEA (nausea) and FATIGUE (fatigue). At the time of the report, DECREASED APPETITE (decreased appetite), DIZZINESS (dizziness), DISORIENTATION (disorientation), FEELING ABNORMAL (felt out of it), NAUSEA (nausea) and FATIGUE (fatigue) outcome was unknown.            No concomitant medicines were included.  treatment drugs were not provided.  Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to US-MODERNATX, INC.-MOD-2021-049844 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: TCR attached. Patient said she is fine now; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-049844:First dose case
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: decreased appetite; dizziness; disorientation; felt out of it; nausea; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (decreased appetite), DIZZINESS (dizziness), DISORIENTATION (disorientation), FEELING ABNORMAL (felt out of it) and NAUSEA (nausea) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030120A and 013A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DECREASED APPETITE (decreased appetite), DIZZINESS (dizziness), DISORIENTATION (disorientation), FEELING ABNORMAL (felt out of it), NAUSEA (nausea) and FATIGUE (fatigue). At the time of the report, DECREASED APPETITE (decreased appetite), DIZZINESS (dizziness), DISORIENTATION (disorientation), FEELING ABNORMAL (felt out of it), NAUSEA (nausea) and FATIGUE (fatigue) outcome was unknown.            No concomitant medicines were included.  treatment drugs were not provided.  Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to US-MODERNATX, INC.-MOD-2021-049844 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: TCR attached. Patient said she is fine now; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-049844:First dose case
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Headache, Insomnia, Pain
Clinical narrative: She couldn't sleep at night because of aches and pain; She had pain in her head and some chills on next day; Patient reports that she felt dizzy after 3-4 hours of receiving 2nd dose; She had pain in her head and some chills on next day; She couldn't sleep at night because of aches and pain; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Patient reports that she felt dizzy after 3-4 hours of receiving 2nd dose), INSOMNIA (She couldn't sleep at night because of aches and pain), PAIN (She couldn't sleep at night because of aches and pain), HEADACHE (She had pain in her head and some chills on next day) and CHILLS (She had pain in her head and some chills on next day) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included VITAMINS NOS for an unknown indication.    On 15-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 15-Mar-2021, the patient experienced INSOMNIA (She couldn't sleep at night because of aches and pain). On 16-Mar-2021, the patient experienced CHILLS (She had pain in her head and some chills on next day). On 18-Mar-2021, the patient experienced DIZZINESS (Patient reports that she felt dizzy after 3-4 hours of receiving 2nd dose). On an unknown date, the patient experienced PAIN (She couldn't sleep at night because of aches and pain) and HEADACHE (She had pain in her head and some chills on next day). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DIZZINESS (Patient reports that she felt dizzy after 3-4 hours of receiving 2nd dose), INSOMNIA (She couldn't sleep at night because of aches and pain), PAIN (She couldn't sleep at night because of aches and pain), HEADACHE (She had pain in her head and some chills on next day) and CHILLS (She had pain in her head and some chills on next day) outcome was unknown. Not Provided          Action taken with mRNA-1273 in response to the events was not applicable.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Accidental overdose, Chest discomfort, Palpitations
Clinical narrative: Patient accidentally received third moderna vaccine; Palpitation; Chest heaviness; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of ACCIDENTAL OVERDOSE (Patient accidentally received third moderna vaccine), PALPITATIONS (Palpitation) and CHEST DISCOMFORT (Chest heaviness) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A, 042L20A and 042L20A) for COVID-19 vaccination.     The patient's past medical history included Hypertension, Brain disorder NOS, Benign prostatic hyperplasia and Cocaine abuse.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Mar-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Mar-2021, the patient experienced ACCIDENTAL OVERDOSE (Patient accidentally received third moderna vaccine), PALPITATIONS (Palpitation) and CHEST DISCOMFORT (Chest heaviness). On 17-Mar-2021, ACCIDENTAL OVERDOSE (Patient accidentally received third moderna vaccine), PALPITATIONS (Palpitation) and CHEST DISCOMFORT (Chest heaviness) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment information given. As patient has taken 2 scheduled doses of the vaccine (3rd being a mistake) the action taken with mRNA-1273 in response to the event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 01-Jun-2021: Follow-up information received on 01-JUN-2021 contains significant information. ADR form received, updated weight of the patient and new events.
Sex: F
Vaccine: COVID19
Symptoms: Accidental exposure to product
Clinical narrative: Vaccine in eyes; A spontaneous report was received from a pharmacist concerning a 30-year-old female patient, who got Moderna's COVID-19 vaccine (mRNA-1273) in her eyes.   The patient's medical history was not provided. Concomitant medication use was not provided by reporter.   On an unknown date, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot number unknown) for COVID-19 infection prophylaxis.   The patient got mRNA-1273 vaccine in her eyes (Accidental contact of product with eye).   No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome was considered resolved for event.; Sender's Comments: This report refers to a case of accidental exposure to product for mRNA-1273 with no associated AEs.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Performance status decreased, Vaccination site pain
Clinical narrative: felt that she was not at peak performance; feeling physically worn out/physically tired; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PERFORMANCE STATUS DECREASED (felt that she was not at peak performance), VACCINATION SITE PAIN (sore arm) and FATIGUE (feeling physically worn out/physically tired) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001BZIA) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced VACCINATION SITE PAIN (sore arm). On 15-Mar-2021, the patient experienced PERFORMANCE STATUS DECREASED (felt that she was not at peak performance) and FATIGUE (feeling physically worn out/physically tired). At the time of the report, PERFORMANCE STATUS DECREASED (felt that she was not at peak performance), VACCINATION SITE PAIN (sore arm) and FATIGUE (feeling physically worn out/physically tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medication was provided
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Covid-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid-19) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced COVID-19 (Covid-19). At the time of the report, COVID-19 (Covid-19) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication not reported.  Treatment medication not reported.   Reporter did not allow further contact; Sender's Comments: Based on the mechanism of action of mRNA 1273 and the etiology of event Covid 19, it is unlikely related to the vaccine.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Job dissatisfaction, Pain in extremity
Clinical narrative: Brother had a sore arm; Could not go to work next day; Extremely tired after receiving 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Brother had a sore arm), JOB DISSATISFACTION (Could not go to work next day) and FATIGUE (Extremely tired after receiving 2nd dose) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Mar-2021, the patient experienced PAIN IN EXTREMITY (Brother had a sore arm), JOB DISSATISFACTION (Could not go to work next day) and FATIGUE (Extremely tired after receiving 2nd dose). At the time of the report, PAIN IN EXTREMITY (Brother had a sore arm), JOB DISSATISFACTION (Could not go to work next day) and FATIGUE (Extremely tired after receiving 2nd dose) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant medication and treatment information were not reported.  The case was crosslinked to MOD21-057208 & MOD21-057247
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pyrexia
Clinical narrative: fever; still tired; This spontaneous case was reported by an other and describes the occurrence of PYREXIA (fever) and FATIGUE (still tired) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever) and FATIGUE (still tired). At the time of the report, PYREXIA (fever) had resolved and FATIGUE (still tired) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Dizziness, Fatigue, Pruritus
Clinical narrative: rash all over the body; chills; soreness around the injection site; light headed; fatigue; feeling weak; itchiness; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchiness), RASH (rash all over the body), FATIGUE (fatigue), ASTHENIA (feeling weak) and CHILLS (chills) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension.    On 11-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced PRURITUS (itchiness), FATIGUE (fatigue), ASTHENIA (feeling weak), VACCINATION SITE PAIN (soreness around the injection site) and DIZZINESS (light headed). On 13-Mar-2021, the patient experienced CHILLS (chills). On 15-Mar-2021, the patient experienced RASH (rash all over the body). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Itchy, at an unspecified dose and frequency. At the time of the report, PRURITUS (itchiness), RASH (rash all over the body), FATIGUE (fatigue), ASTHENIA (feeling weak), CHILLS (chills), VACCINATION SITE PAIN (soreness around the injection site) and DIZZINESS (light headed) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Benadryl was taken as treatment for itchiness.  Concomitant medications were used for high blood pressure.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Vaccination site pain
Clinical narrative: rash all over the body; chills; soreness around the injection site; light headed; fatigue; feeling weak; itchiness; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchiness), RASH (rash all over the body), FATIGUE (fatigue), ASTHENIA (feeling weak) and CHILLS (chills) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension.    On 11-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced PRURITUS (itchiness), FATIGUE (fatigue), ASTHENIA (feeling weak), VACCINATION SITE PAIN (soreness around the injection site) and DIZZINESS (light headed). On 13-Mar-2021, the patient experienced CHILLS (chills). On 15-Mar-2021, the patient experienced RASH (rash all over the body). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Itchy, at an unspecified dose and frequency. At the time of the report, PRURITUS (itchiness), RASH (rash all over the body), FATIGUE (fatigue), ASTHENIA (feeling weak), CHILLS (chills), VACCINATION SITE PAIN (soreness around the injection site) and DIZZINESS (light headed) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Benadryl was taken as treatment for itchiness.  Concomitant medications were used for high blood pressure.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Pyrexia, Vaccination site erythema
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (localized red reaction at the injection site), PYREXIA (Fever) and INJECTION SITE ERYTHEMA (red circle around the injection site(size as the palm of her hand)) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (localized red reaction at the injection site). On 07-Mar-2021, the patient experienced PYREXIA (Fever) and INJECTION SITE ERYTHEMA (red circle around the injection site(size as the palm of her hand)). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form; IBUPROFEN at a dose of 1 dosage form and HISTAMINE at a dose of 1 dosage form. At the time of the report, VACCINATION SITE ERYTHEMA (localized red reaction at the injection site), PYREXIA (Fever) and INJECTION SITE ERYTHEMA (red circle around the injection site(size as the palm of her hand)) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient reported no concomitant medication.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Vaccination site pain, Vaccination site pruritus, Vaccination site rash, Vaccination site warmth
Clinical narrative: vaccination site pain; Warm spot; itchy red rash; vaccination site pain; Vaccination site rash; lymph nodes under left armpit were noticeble swollen and tender; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (shooting pain/pain in left arm/armpit), VACCINATION SITE WARMTH (Warm spot), VACCINATION SITE PRURITUS (itchy red rash), VACCINATION SITE SWELLING (Swollen spot) and VACCINATION SITE ERYTHEMA (itchy red rash) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy to antibiotic (Cipro) and Drug allergy (Codeine).    On 06-Mar-2021 at 3:45 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021 at 10:00 AM, the patient experienced PAIN IN EXTREMITY (shooting pain/pain in left arm/armpit), VACCINATION SITE WARMTH (Warm spot), VACCINATION SITE PRURITUS (itchy red rash), VACCINATION SITE SWELLING (Swollen spot), VACCINATION SITE ERYTHEMA (itchy red rash) and LYMPHADENOPATHY (lymph nodes under left armpit were noticeble swollen and tender). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency. On 25-Mar-2021, PAIN IN EXTREMITY (shooting pain/pain in left arm/armpit), VACCINATION SITE WARMTH (Warm spot), VACCINATION SITE PRURITUS (itchy red rash), VACCINATION SITE SWELLING (Swollen spot), VACCINATION SITE ERYTHEMA (itchy red rash) and LYMPHADENOPATHY (lymph nodes under left armpit were noticeble swollen and tender) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication were reported. There was no recurrence of these symptoms with the second dose.   Most recent FOLLOW-UP information incorporated above includes: On 13-Jun-2021: Follow-up information received provided patient details, suspect dosage details, event details and outcome.
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: I continue to have severe breathing issues; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (I continue to have severe breathing issues) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced DYSPNOEA (I continue to have severe breathing issues). At the time of the report, DYSPNOEA (I continue to have severe breathing issues) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant and treatment information were not provided.   Reporter did not allow further contact
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Mass, Pain in extremity, Peripheral swelling
Clinical narrative: she had "covid arm"; a lump; red; swollen; itchy; painful; she felt warm inside for some minutes; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (she felt warm inside for some minutes), TYPE IV HYPERSENSITIVITY REACTION (she had "covid arm"), MASS (a lump), ERYTHEMA (red) and PERIPHERAL SWELLING (swollen) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse effect. Concomitant products included HYDROXYCHLOROQUINE SULFATE (PLAQUENIL S), HYDROXYCHLOROQUINE, ENALAPRIL and AMLODIPINE for an unknown indication.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced FEELING HOT (she felt warm inside for some minutes). On 27-Feb-2021, the patient experienced TYPE IV HYPERSENSITIVITY REACTION (she had "covid arm"), MASS (a lump), ERYTHEMA (red), PERIPHERAL SWELLING (swollen), PRURITUS (itchy) and PAIN IN EXTREMITY (painful). On 20-Feb-2021, FEELING HOT (she felt warm inside for some minutes) had resolved. On 05-Mar-2021, TYPE IV HYPERSENSITIVITY REACTION (she had "covid arm"), MASS (a lump), ERYTHEMA (red), PERIPHERAL SWELLING (swollen), PRURITUS (itchy) and PAIN IN EXTREMITY (painful) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Tylenol, hot and warm compresses were taken as treatment
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Type IV hypersensitivity reaction
Clinical narrative: she had "covid arm"; a lump; red; swollen; itchy; painful; she felt warm inside for some minutes; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (she felt warm inside for some minutes), TYPE IV HYPERSENSITIVITY REACTION (she had "covid arm"), MASS (a lump), ERYTHEMA (red) and PERIPHERAL SWELLING (swollen) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse effect. Concomitant products included HYDROXYCHLOROQUINE SULFATE (PLAQUENIL S), HYDROXYCHLOROQUINE, ENALAPRIL and AMLODIPINE for an unknown indication.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced FEELING HOT (she felt warm inside for some minutes). On 27-Feb-2021, the patient experienced TYPE IV HYPERSENSITIVITY REACTION (she had "covid arm"), MASS (a lump), ERYTHEMA (red), PERIPHERAL SWELLING (swollen), PRURITUS (itchy) and PAIN IN EXTREMITY (painful). On 20-Feb-2021, FEELING HOT (she felt warm inside for some minutes) had resolved. On 05-Mar-2021, TYPE IV HYPERSENSITIVITY REACTION (she had "covid arm"), MASS (a lump), ERYTHEMA (red), PERIPHERAL SWELLING (swollen), PRURITUS (itchy) and PAIN IN EXTREMITY (painful) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Tylenol, hot and warm compresses were taken as treatment
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Condition aggravated, Depression, Fatigue, Feeling abnormal
Clinical narrative: backache; depression got worse; depression worse; don't feel good; Headache; sore left arm; achy all over; mild fever; tiredness; Swelling in lymph nodes on both sides; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (backache), DEPRESSION (depression got worse), CONDITION AGGRAVATED (depression worse), FEELING ABNORMAL (don't feel good) and LYMPHADENOPATHY (Swelling in lymph nodes on both sides) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048A21A and 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Surgery (right breast surgery). Concurrent medical conditions included Depression. Concomitant products included LISINOPRIL for Blood pressure high, ESCITALOPRAM OXALATE (LEXAPRO) for Depression, CALCIUM, COLECALCIFEROL (CALCIUM AND VIT D) for Osteoporosis, FEXOFENADINE HYDROCHLORIDE (ALLEGRA), CELECOXIB (ZOBREX), MONTELUKAST SODIUM (SINGULAIR) and MACROGOL 3350 (MIRALAX) for an unknown indication.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. In March 2021, the patient experienced LYMPHADENOPATHY (Swelling in lymph nodes on both sides). On an unknown date, the patient experienced BACK PAIN (backache), DEPRESSION (depression got worse), CONDITION AGGRAVATED (depression worse), FEELING ABNORMAL (don't feel good), HEADACHE (Headache), VACCINATION SITE PAIN (sore left arm), MYALGIA (achy all over), PYREXIA (mild fever) and FATIGUE (tiredness). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Headache, at a dose of 1 dosage form. At the time of the report, BACK PAIN (backache), FEELING ABNORMAL (don't feel good), VACCINATION SITE PAIN (sore left arm), MYALGIA (achy all over) and PYREXIA (mild fever) outcome was unknown, DEPRESSION (depression got worse), CONDITION AGGRAVATED (depression worse) and FATIGUE (tiredness) had not resolved, LYMPHADENOPATHY (Swelling in lymph nodes on both sides) had resolved and HEADACHE (Headache) was resolving.            Action taken with mRNA-1273 in response to the events was not applicable.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to US-MODERNATX, INC.-MOD-2021-049893 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: Added con meds, added treatment medication, added event On 10-May-2021: Follow-up information received on 10-May-2021 contains no significant information
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Lymphadenopathy, Myalgia, Pyrexia, Vaccination site pain
Clinical narrative: backache; depression got worse; depression worse; don't feel good; Headache; sore left arm; achy all over; mild fever; tiredness; Swelling in lymph nodes on both sides; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (backache), DEPRESSION (depression got worse), CONDITION AGGRAVATED (depression worse), FEELING ABNORMAL (don't feel good) and LYMPHADENOPATHY (Swelling in lymph nodes on both sides) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048A21A and 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Surgery (right breast surgery). Concurrent medical conditions included Depression. Concomitant products included LISINOPRIL for Blood pressure high, ESCITALOPRAM OXALATE (LEXAPRO) for Depression, CALCIUM, COLECALCIFEROL (CALCIUM AND VIT D) for Osteoporosis, FEXOFENADINE HYDROCHLORIDE (ALLEGRA), CELECOXIB (ZOBREX), MONTELUKAST SODIUM (SINGULAIR) and MACROGOL 3350 (MIRALAX) for an unknown indication.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. In March 2021, the patient experienced LYMPHADENOPATHY (Swelling in lymph nodes on both sides). On an unknown date, the patient experienced BACK PAIN (backache), DEPRESSION (depression got worse), CONDITION AGGRAVATED (depression worse), FEELING ABNORMAL (don't feel good), HEADACHE (Headache), VACCINATION SITE PAIN (sore left arm), MYALGIA (achy all over), PYREXIA (mild fever) and FATIGUE (tiredness). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Headache, at a dose of 1 dosage form. At the time of the report, BACK PAIN (backache), FEELING ABNORMAL (don't feel good), VACCINATION SITE PAIN (sore left arm), MYALGIA (achy all over) and PYREXIA (mild fever) outcome was unknown, DEPRESSION (depression got worse), CONDITION AGGRAVATED (depression worse) and FATIGUE (tiredness) had not resolved, LYMPHADENOPATHY (Swelling in lymph nodes on both sides) had resolved and HEADACHE (Headache) was resolving.            Action taken with mRNA-1273 in response to the events was not applicable.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to US-MODERNATX, INC.-MOD-2021-049893 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: Added con meds, added treatment medication, added event On 10-May-2021: Follow-up information received on 10-May-2021 contains no significant information
Sex: U
Vaccine: COVID19
Symptoms: Off label use
Clinical narrative: she is over the 1 month period; This spontaneous case was reported by a consumer and describes the occurrence of OFF LABEL USE (she is over the 1 month period) in a 67-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20-2A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced OFF LABEL USE (she is over the 1 month period). At the time of the report, OFF LABEL USE (she is over the 1 month period) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  No concomitant medications were reported. No treatment related information has been reported.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Nasopharyngitis
Clinical narrative: cold; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (cold) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced NASOPHARYNGITIS (cold). At the time of the report, NASOPHARYNGITIS (cold) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided. Patient experienced cold after receiving first dose of Moderna vaccine.   This case was linked to US-MODERNATX, INC.-MOD-2021-049740 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-049740:MOD21-056826 : Same reporter, reporter's husband
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Pain in extremity
Clinical narrative: legs start hurting so bad; knees were hurting; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (legs start hurting so bad) and ARTHRALGIA (knees were hurting) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (legs start hurting so bad) and ARTHRALGIA (knees were hurting). At the time of the report, PAIN IN EXTREMITY (legs start hurting so bad) and ARTHRALGIA (knees were hurting) outcome was unknown. Not Provided          no concomitant medications reported. no treatment details reported.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site rash
Clinical narrative: Bad Rash at the injection site; Red at the injection site; Itchy at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Bad Rash at the injection site), VACCINATION SITE ERYTHEMA (Red at the injection site) and VACCINATION SITE PRURITUS (Itchy at the injection site) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006M20A and 003A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Mar-2021, the patient experienced VACCINATION SITE RASH (Bad Rash at the injection site), VACCINATION SITE ERYTHEMA (Red at the injection site) and VACCINATION SITE PRURITUS (Itchy at the injection site). At the time of the report, VACCINATION SITE RASH (Bad Rash at the injection site), VACCINATION SITE ERYTHEMA (Red at the injection site) and VACCINATION SITE PRURITUS (Itchy at the injection site) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications are not provided by the reporter. No treatment drugs are not provided by reporter.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Intentional dose omission, Nervousness, Tremor
Clinical narrative: Will not be receiving the 2nd dose; hands shake; shaky and internal shake; This spontaneous case was reported by a consumer and describes the occurrence of NERVOUSNESS (shaky and internal shake), TREMOR (hands shake) and INTENTIONAL DOSE OMISSION (Will not be receiving the 2nd dose) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.  No Medical History information was reported.  On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced TREMOR (hands shake). On 13-Mar-2021, the patient experienced NERVOUSNESS (shaky and internal shake). On an unknown date, the patient experienced INTENTIONAL DOSE OMISSION (Will not be receiving the 2nd dose). At the time of the report, NERVOUSNESS (shaky and internal shake) and TREMOR (hands shake) outcome was unknown and INTENTIONAL DOSE OMISSION (Will not be receiving the 2nd dose) had resolved. Not Related      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications provided. No treatment information provided.   Most recent FOLLOW-UP information incorporated above includes: On 14-May-2021: Follow up received on 14-MAY-2021 and contains non significant information.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Ultrasound scan
Clinical narrative: Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 30-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     The patient's past medical history included Polycystic ovary. Concomitant products included SERTRALINE HYDROCHLORIDE (ZOLOFT) for an unknown indication.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 07-Sep-2020 and the estimated date of delivery was 23-Jun-2021. On 12-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-sixth week of the pregnancy.  At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Feb-2020, Ultrasound scan: normal (normal) Normal. On 24-Feb-2021, Ultrasound scan: normal (normal) Normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications were not reported. On 09 Jan 2019 patient had previous pregnancy which was live and full term birth.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Blood glucose increased
Clinical narrative: really low energy/feeling weak; blood sugar has gone up; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (really low energy/feeling weak) and BLOOD GLUCOSE INCREASED (blood sugar has gone up) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (really low energy/feeling weak) and BLOOD GLUCOSE INCREASED (blood sugar has gone up). At the time of the report, ASTHENIA (really low energy/feeling weak) and BLOOD GLUCOSE INCREASED (blood sugar has gone up) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication reported by the reporter.  No treatment medication reported by the reporter.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Ear pain, Erythema, Headache, Pain
Clinical narrative: Bright red cheeks; Throbbing; Bad ear ache; had a little bit of a headache; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Bright red cheeks), PAIN (Throbbing), EAR PAIN (Bad ear ache) and HEADACHE (had a little bit of a headache) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     The patient's past medical history included Trigeminal neuralgia since an unknown date. Concurrent medical conditions included Drug allergy, Drug allergy, Drug allergy and Drug allergy. Concomitant products included INSULIN DEGLUDEC (TRESIBA), SEMAGLUTIDE (OZEMPIC), SOTALOL, APIXABAN (ELIQUIS), HYDROCODONE, ATORVASTATIN, CENTRUM SILVER +50 and VALACICLOVIR HYDROCHLORIDE (VALTREX) for an unknown indication.   On 10-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Mar-2021, the patient experienced ERYTHEMA (Bright red cheeks), PAIN (Throbbing), EAR PAIN (Bad ear ache) and HEADACHE (had a little bit of a headache). At the time of the report, ERYTHEMA (Bright red cheeks), PAIN (Throbbing), EAR PAIN (Bad ear ache) and HEADACHE (had a little bit of a headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Mar-2021, Body temperature: high Farad (High) Temperature of 101 F.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Lip swelling, Rash, Swelling face, Throat tightness
Clinical narrative: Woke up at 4:30am with a horrible rash all over arms, legs, torso, head.  Jaw started to stiffen with difficulty breathing.  At emergency room face and lips started to swell terribly.  Throat started to tighten. Emergency staff have given me prednisone, Benadryl and a shot of epinephrine.  They are continuing to monitor me.
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Infection, SARS-CoV-2 test positive
Clinical narrative: breakthrough covid case requiring hospital admission on 8/14/2021
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Arrhythmia, Blood test, Cardiac monitoring, Electrocardiogram, Palpitations
Clinical narrative: Heart Arrhythmia (pounding heart), motoprolol succinate 25mg 1xday  Small improvement
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Burning sensation, Condition aggravated, Dysgeusia, Fibromyalgia
Clinical narrative: Immediately after getting the shot I developed a metal taste in my mouth. I was sweating and shaky. By the time I got home, I had severe burning in both feet and legs. Sunday morning I woke up to severe neck pain and shoulder blade pain, stiffness in my neck and shoulders and a neuropathic burning in my feet.  I attributed it to an acute exacerbation of fibromyalgia that I develop after any flu vaccine.  It was 4 weeks before I began to feel better, then I developed a sensation of ringing or gurgling in my left ear, the same side that I got the shot in. It took two months for my hearing to clear up in that ear. It was not an infection, seasonal allergies or wax in my ear.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hyperhidrosis, Immediate post-injection reaction, Musculoskeletal stiffness, Neck pain, Tinnitus
Clinical narrative: Immediately after getting the shot I developed a metal taste in my mouth. I was sweating and shaky. By the time I got home, I had severe burning in both feet and legs. Sunday morning I woke up to severe neck pain and shoulder blade pain, stiffness in my neck and shoulders and a neuropathic burning in my feet.  I attributed it to an acute exacerbation of fibromyalgia that I develop after any flu vaccine.  It was 4 weeks before I began to feel better, then I developed a sensation of ringing or gurgling in my left ear, the same side that I got the shot in. It took two months for my hearing to clear up in that ear. It was not an infection, seasonal allergies or wax in my ear.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tremor
Clinical narrative: Immediately after getting the shot I developed a metal taste in my mouth. I was sweating and shaky. By the time I got home, I had severe burning in both feet and legs. Sunday morning I woke up to severe neck pain and shoulder blade pain, stiffness in my neck and shoulders and a neuropathic burning in my feet.  I attributed it to an acute exacerbation of fibromyalgia that I develop after any flu vaccine.  It was 4 weeks before I began to feel better, then I developed a sensation of ringing or gurgling in my left ear, the same side that I got the shot in. It took two months for my hearing to clear up in that ear. It was not an infection, seasonal allergies or wax in my ear.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fibromyalgia, Meningitis, Musculoskeletal pain, Musculoskeletal stiffness, Neck pain
Clinical narrative: Immediately after getting the shot I developed a metal taste in my mouth. I was sweating and shaky. By the time I got home, I had severe burning in both feet and legs. Sunday morning I woke up to severe neck pain and shoulder blade pain, stiffness in my neck and shoulders and a neuropathic burning in my feet.  I attributed it to an acute exacerbation of fibromyalgia that I develop after any flu vaccine.  It was 4 weeks before I began to feel better, then I developed a sensation of ringing or gurgling in my left ear, the same side that I got the shot in. It took two months for my hearing to clear up in that ear. It was not an infection, seasonal allergies or wax in my ear.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Rash erythematous, Rash pruritic
Clinical narrative: I got red spots in different parts on my body. Some of them are more itchy than other. They start showing while I am sleeping. Earlier I thought they are bed bugs till I checked with my brother and another two friends. They got exactly the same. Also this comes and agoes
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, Rash erythematous, Vaccine positive rechallenge
Clinical narrative: A few days after receiving my vaccine, a reddish slightly raised small shape appeared under my chest. Over the next several days, I started to develop more of these same marks (different sizes) on my stomach, under chest, and and on back. I didn't feel them at all and they aren't itchy.  I sent this information, and photos, to my dermatologist at the time, who suggested it might be pityriasis rosea, might last up to 3 months.  After my second Pfizer dose (Lot #EL9266) on 2/15/2021, the old spots had disappeared but some new ones started to pop up on 2/15 (again I sent photos and information to my dermatologist at the time, so I have contemporaneous record keeping). I didn't feel the new marks at all, they were barely raised, and mostly appearing on my side of my abdomen (notably the same side as the first appearances) and under my chest.  Today, 8/15/2021, 6 months later, I have a few of the same rashes still left over from 2/15/2021. They are very faded, but still visible, and the same exact rashes from 2/15.   I am reporting this information because I see on Google now that pityriasis rosea is a known possible side effect of the COVID vaccine. I thought I should share this information with the CDC.